Stable expression and secretion of the B-cell epitope of rodent malaria from Mycobacterium bovis BCG and induction of long-lasting humoral response in mouse

Vaccine

Volumn 14, Issue 1, 1996, Pages 54-60

  Matsumoto, S ^a   Yanagi, T ^a   Ohara, N ^a   Wada, N ^a   Kanbara, H ^a   Yamada, T ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

BCG; Malaria; Recombinant vaccine

Indexed keywords

BCG VACCINE; EPITOPE; RECOMBINANT VACCINE;

ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; MALARIA; MOUSE; MYCOBACTERIUM BOVIS; NONHUMAN; PLASMODIUM YOELII; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTIBODIES, PROTOZOAN; B-LYMPHOCYTES; BCG VACCINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; GENETIC VECTORS; MALARIA; MICE; MICE, INBRED BALB C; PLASMODIUM YOELII; RECOMBINANT FUSION PROTEINS; VACCINES, SYNTHETIC;

EID: 0030049068     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00131-J     Document Type: Article

References (42)

1. Millet, P., Kalish, M.L, Collins, W.E and Hunter, R.L. Effect of adjuvant formulations on the selection of B-cell epitopes expressed by a malaria peptide vaccine. Vaccine 1992, 10, 547-550
2. Herrera, S., Herrera, M.A., Corredor, A., Rosero, F., Clavijo, C. and Guerrero, R. Failure of a synthetic vaccine to protect Aotus lemurinus against asexual blood stages of Plasmodium falciparum. Am. J. Trop. Med. Hyg 1992, 47, 682-690
3. Barletta, R.G., Snapper, B., Cirillo, J.D. et al. Recombinant BCG as a candidate oral vaccine vector. Res. Microbiol. 1990, 141, 931-939
4. Stover, C.K., de la Cruz, V.F., Fuerst, T.R. et al. New use of BCG for recombinant vaccines. Nature 1991, 351, 456-460
5. Jacobs, W.J., Tuckman, M. and Bloom, B.R. Introduction of foreign DNA into Mycobacteria using a shuttle plasmid. Nature 1987, 327, 532-535
6. Matsuo, K., Yamaguchi, R., Yamazaki, A. et al. Establishment of a foreign antigen secretion system in Mycobacteria. Infect. Immun. 1990, 58, 4049-4054
7. Aldovini, A. and Young, R.A. Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines. Nature 1991, 351, 479-482
8. Kameoka, M., Nishino, Y., Matsuo, K. et al. Cytotoxic T lymphocyte response in mice induced by a recombinant BCG vaccination which produces an extracellular alpha antigen that fused with the human immunodeficiency virus type 1 envelope immunodominant domain in the V3 loop. Vaccine 1994, 12, 153-158
9. Winter, N., Lagranderie, M., Rauzier, J. et al. Expression of heterologous genes in Mycobacterium bovis BCG: induction of a cellular response against HIV-1 Nef protein. Gene 1991, 109, 47-54
10. Fuerst, T.R, Stover, C.K., and de la Cruz, V.F. Development of BCG as a live recombinant vector system: potential use as an HIV vaccine. Biotechnol. Ther. 1991, 2, 159-178
11. Stover, C.K., Bansal, G.P., Hanson, M.S. et al. Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine. J. Exp. Med 1993, 178, 197-209
12. Yasutomi, Y., Koenig, S., Haun, S.S. et al. Immunization with recombinant BCG-SIV elicits SIV-specific cytotoxic T lymphocytes in rhesus monkeys. J. Immunol. 1993, 150, 3101-3107
13. Lagranderie, M., Murray, A., Gicquel, B., Leclerc, C. and Gheorghiu, M. Oral immunization with recombinant BCG induces cellular and humoral immune responses against the foreign antigen. Vaccine 1993, 11, 1283-1290
14. Haeseleer, F., Pollet, J.F., Haumont, M., Bollen, A. and Jacobs, P. Stable integration and expression of the Plasmodium falciparum circumsporozoite protein coding sequence in Mycobacteria. Mol. Biochem. Parasitol. 1993, 57, 117-126
15. Connell, N.D., Medina, A.E., McMaster, W.R., Bloom, B.R. and Russell, D.G. Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guerin expressing the Leishmania surface proteinase gp63. Proc. Natl Acad. Sci. USA 1993, 90, 11473-11477
16. Langermann, S., Palaszynski, S., Sadziene, A., Stover, C.K. and Koenig, S. Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi. Nature 1994, 372, 552-555
17. O'Donnell, M.A., Aldovini, A., Duda, R.B. et al. Recombinant Mycobacterium bovis BCG secreting functional interleukin-2 enhances gamma Interferon production by splenocytes. Infect. Immun. 1994, 62, 2508-2514
18. Langermann, S., Palaszynski, S.R., Burlein, J.E. et al. Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guerin vaccines expressing pneumococcal surface protein A. J. Exp. Med. 1994, 180, 2277-2286
19. Nussenzweig, R.S. and Long, C.A. (Review) Malaria vaccines: multiple targets. Science 1994, 265, 1381-1383
20. Coppel, R.L., Cowman, A.F., Anders, R.F. et al. Immune sera recognize on erythrocytes Plasmodium falciparum antigen composed of repeated amino acid sequences. Nature 1984, 310, 789-792
21. Collins, W.E., Anders, R.F., Pappaioanou, M. et al. Immunization of Aotus monkeys with recombinant proteins of an erythrocyte surface antigen of Plasmodium falciparum. Nature 1986, 323, 259-262
22. Kaslow, D.C., Quakyi, I.A., Syin, C. et al. A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains. Nature 1988, 333, 7476
23. Romero, P., Maryanski, J.L., Corradin, G., Nussenzweig, R.S., Nussenzweig, V. and Zavala, F. Cloned cytotoxic T-cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 1989, 341, 323-326
24. Hill, A.V., Elvin, J., Willis, A.C. et al. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 1992, 360, 434-439
25. Nussenzweig, R.S. and Nussenzweig, V. Antisporozoite vaccine for malaria: experimental basis and current status. Rev. Infect. Dis. 1989, 11, 579-585
26. Dame, J.B., Williams, J.L., McCutchan, T.R et al. Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum. Science 1984, 225, 593-599
27. Arnot, D.E., Barnwell, J.W., Tarn, J.P., Nussenzweig, V., Nussenzweig, R.S. and Enea, V. Circumsporozoite protein of Plasmodium vivax: gene cloning and characterization of the immunodominant epitope. Science 1985, 230, 815-818
28. Vergara, U., Gwadz, R., Schlesinger, D., Nussenzweig, V. and Rerreira, A. Multiple non-repeated epitopes on the circumsporozoite protein of Plasmodium knowlesi. Mol. Biochem. Parasitol. 1985, 14, 283-292
29. McCutchan, T.F., Lal, A.A., de la Cruz, V.F. et al. Sequence of the immunodominant epitope for the surface protein on sporozoites of Plasmodium vivax. Science 1985, 230, 1381-1383
30. Gibson, K.D. and Scheraga, H.A. Predicted conformations for the immunodominant region of the circumsporozoite protein of the human malaria parasite Plasmodium falciparum. Proc. Natl Acad. Sci. USA 1986, 83, 5649-5653
31. Galinski, M.R., Arnot, D.E., Cochrane, A.M., Barnwell, J.W., Nussenzweig, R.S. and Enea, V. The circumsporozoite gene of the Plasmodium cynomolgi complex. Cell 1987, 40, 311-319
32. Lal, A.A., de la Cruz, V.F., Welsh, J.A., Charoenvit, Y., Maloy, W.L. and McCutchan, T.F. Structure of the gene encoding the circumsporozoite protein of Plasmodium yoelii. A rodent model for examining antimalarial sporozoite vaccines. J. Biol. Chem. 1987, 262, 2937-2940
33. Ballou, W.R., Hoffman, S.L., Sherwood, J.A. et al. Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine. Lancet 1987, 1, 1277-1281
34. Herrington, D.A., Clyde, D.F., Losonsky, G. et al. Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites. Nature 1987, 328, 257-259
35. Lussow, A.R., Del, G.G., Renia, L. et al. Use of a tuberculin purified protein derivative-Asn-Ala-Asn-Pro conjugate in bacillus Calmette-Guerin primed mice overcomes H-2 restriction of the antibody response and avoids the need for adjuvants. Proc. Natl Acad. Sci. USA 1990, 87, 2960-2964
36. Matsuo, K., Yamaguchi, R., Yamazaki, A., Tasaka, H., Terasaka, K. and Yamada, T. Cloning and expression of the gene for the cross-reactive alpha antigen of Mycobacterium kansasii. Infect. Immun. 1990, 58, 550-556
37. Closs, O., Harboe, M., Axelsen, N.H., Bunch, C.K. and Magnusson, M. The antigens of Mycobacterium bovis, strain BCG, studied by crossed immunoelectrophoresis: a reference system. Scand. J. Immunol. 1980, 12, 249-263
38. De, B.J., Huygen, K., Bosnians, R. et al. Purification, characterization and identification of a 32 kDa protein antigen of Mycobacterium bovis BCG. Microb. Pathog. 1987, 2, 351-366
39. Wiker, H.G., Harboe, M., Nagai, S. and Bennedsen, J. Quantitative and qualitative studies on the major extracellular antigen of Mycobacterium tuberculosis H37Rv and Mycobacterium bovis BCG. Am. Rev. Respir. Dis. 1990, 140, 830-838
40. Content, J., de la Cuvellerie, A., De Wit, L., Vincent-Levy-Frebault, V., Ooms, J. and De Bruyn, J. The genes coding for the antigen 85 complexes of Mycobacterium tuberculosis and Mycobacterium bovis BCG are members of a gene family: cloning, sequence determination, and genomic organization of the gene coding for antigen 85-C of M. tuberculosis. Infect Immun. 1991, 59, 3205-3212
41. Boom, W.H., Wallis, R.S. and Chervenak, K.A. Human Mycobacterium tuberculosis-reactive CD4+ T-cell clones: heterogeneity in antigen recognition, cytokine production, and cytotoxicity for mononuclear phagocytes. Infect. Immun. 1991, 59, 2737-2743
42. Huygen, K., Abramowicz, D., Vandenbussche, P. et al. Spleen cell cytokine secretion in Mycobacterium bovis BCG-infected mice. Infect. Immun. 1992, 60, 2880-2886